Snowball logo
logo
DRMA

Dermata Therapeutics Inc

DRMA • NASDAQ
$0.679-$0.039  (5.43%)
Estimate
EPS
-4.2
Beta
0.692
Growth
Net income, YoY
-74.42%
FCF, YoY
5.88%
Forecast
EPS (FWD)
-1.43
About the company
Ticker
DRMA
ISIN
US2498451085
Country
United States of America
Sector (GICS)
Healthcare
Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

Frequently asked questions

What sector does Dermata Therapeutics Inc (DRMA) operate in?

Dermata Therapeutics Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Dermata Therapeutics Inc (DRMA) current stock price?

As of the latest data, Dermata Therapeutics Inc stock price is $0.68, with a previous close of $0.72. Dermata Therapeutics Inc lost -$0.04 in the last trading session, representing a -5.43% loss.

What is Dermata Therapeutics Inc (DRMA) current market capitalization?

Dermata Therapeutics Inc market cap is approximately 3.36 million.

What is Dermata Therapeutics Inc (DRMA) Earnings Per Share (EPS)?

The trailing EPS is -$4.20, and the forward EPS is -$1.43.

What is Dermata Therapeutics Inc (DRMA) EBITDA?

Dermata Therapeutics Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -2.97 million.

Does Dermata Therapeutics Inc (DRMA) pay dividends?

No. Dermata Therapeutics Inc does not pay a dividend.

What is Dermata Therapeutics Inc (DRMA) beta (volatility) score?

Dermata Therapeutics Inc has a beta of 0.692, indicating lower volatility than the overall market.